Search Icon
KTTA Archived Articles

Pasithea Therapeutics Corp. (NASDAQ:KTTA): A Biotech Innovator Advancing Groundbreaking Treatments for CNS Disorders and Rare Diseases

Published on November 30, 2024

KTTA: A Promising Biotech Firm Advancing Innovative CNS Therapies

Published on September 24, 2024